Literature DB >> 15691431

[Integral control of risk factors in patients of high and very high cardiovascular risk in Spain. CIFARC project].

Andrés de la Peña Fernández1, Carmen Suárez Fernández, Ignacio Cuende Melero, Manuel Muñoz Rodríguez, José Garré Cánovas, Miguel Camafort Babkowski, Bernardino Roca Villanueva, José Alcalá Pedraja.   

Abstract

BACKGROUND AND
OBJECTIVE: The objective of this study was to determine the percentage of patients with high and very high cardiovascular risk, with their risk factors globally well controlled (hypertension, dyslipemia, diabetes mellitus, tobacco and obesity). PATIENTS AND
METHOD: Transversal study of ambulatory patients of internal medicine with an estimated cardiovascular risk high or very high (Framingham stratification scale over 20% in ten years). We evaluated the degree of control of their cardiovascular risk factors attending to the recommendations provided by recent international guidelines (WHO/ISH, JNC-VI, NCEP-ATP-III, ADA).
RESULTS: We studied 2,264 patients (53.7% males; mean age: 66.1 +/- 11.5 years; 74.6% hypertensive, 61.1% dyslipidemic, 59.8% type 2 diabetes, 31.1% smokers, 38.0% obese and 36.7% in secondary prevention). Control of hypertension was achieved in 34.5%, dyslipidemia in 50.3% and diabetes in 35.5%. Global control of every risk factor was achieved in 6.9% (in 10.2% if we exclude obesity since it is not a risk factor used for cardiovascular stratification). Factors independently associated with a bad integral control were: diabetes (OR = 0.33; 95%CI: 0.23-0.47), dyslipidemia (OR = 0.34; 95%CI: 0.24-0.48), proteinuria (OR = 0.36; 95%CI: 0.18-0.71). Factors independently associated with a better cardiovascular control were: male sex (OR = 1.67; 95%CI: 1.18-2.38), ventricular hypertrophy (OR = 1.62; 95%CI: 1.15-2.30) and the number of exploratory tests (OR = 1.01; 95%CI: 1.01-1.08).
CONCLUSIONS: Only 6.9% of patients with a high or very high cardiovascular risk have all their principal risk factors under control. The presence of diabetes, dyslipidemia or proteinuria predisposed to a worse control and the number of complementary tests performed to the patients was related to a better control.

Entities:  

Mesh:

Year:  2005        PMID: 15691431     DOI: 10.1157/13070450

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  4 in total

1.  [Evaluation and improvement in the prescribing of anti-platelet drugs in diabetic patients].

Authors:  Dolores Aroca García; Pahola Gómez Rivas; María Carmen López Lax
Journal:  Aten Primaria       Date:  2010-03-20       Impact factor: 1.137

2.  [Lifestyles of subjects who take drugs for two or more cardiovascular risk factors. TAR-RISC Study].

Authors:  Josep Carles Llop Margalef; Silvia Hernández Anadón; Josep Bítria Ibars; Albert Josa; José María Crespo; Ferran Bejarano Romero; Carles Llor
Journal:  Aten Primaria       Date:  2010-05-20       Impact factor: 1.137

3.  [Durability of the effects of a quality improvement intervention in hypertensive patients on long-term follow-up (CICLO-RISK study)].

Authors:  Manuel Angel Gómez Marcos; Emiliano Rodríguez Sánchez; Emilio Ramos Delgado; Carmen Fernández Alonso; Angel Luis Montejo Gónzalez; Luis García Ortiz
Journal:  Aten Primaria       Date:  2009-05-15       Impact factor: 1.137

4.  [Dyslipidemia management in patients with high cardiovascular risk in Spain. ALMA study].

Authors:  Xavier Pintó; Ferran Trias Vilagut; Joan Rius Taruella; Esther Mairal Sallán
Journal:  Aten Primaria       Date:  2017-06-12       Impact factor: 1.137

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.